Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LIXT
LIXT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LIXT News
LIXTE Biotechnology Partners with IBN to Enhance Cancer Treatment Awareness
Jan 13 2026
Globenewswire
Lixte Biotechnology Secures $4.3 Million Financing for Cancer Treatment Development
Dec 22 2025
Globenewswire
Lixte Biotechnology Secures $4.3 Million in Registered Direct Offering
Dec 18 2025
Newsfilter
LIXTE Acquires Liora Technologies to Advance Cancer Treatment Standards
Nov 25 2025
Newsfilter
Biotech Stocks Surge After Hours: Insider Purchases, Trial Progress, and Strategic Partnerships Drive Growth
Sep 11 2025
NASDAQ.COM
LIXTE Unveils LB-100 at Inaugural Global Conference on Oncogenic Signaling Activation for Cancer Treatment in 24/7 Market News
Aug 27 2025
Yahoo Finance
Around-the-Clock Market Update: LIXTE Aims at Significant Unaddressed Oncology Markets
Aug 25 2025
Newsfilter
24/7 Market Update: LIXTE Biotechnology Focus - Reevaluating the "Excessive Benefits" Approach for LB-100
Aug 19 2025
Newsfilter
24/7 Market Update: LIXTE Biotechnology Focus - Reevaluating the "Excessive Benefits" Approach for LB-100
Aug 19 2025
Yahoo Finance
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025
Aug 15 2025
Yahoo Finance
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
Aug 14 2025
Newsfilter
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering
Jul 09 2025
Globenewswire
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket
Jul 07 2025
Benzinga
Dow Jumps Over 200 Points; US Nonfarm Payrolls Beat Estimates
Jul 03 2025
Benzinga
Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market
Jul 02 2025
Newsfilter
Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market
Jul 01 2025
Newsfilter
Show More News
